Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease

Acute graft-versus-host disease (aGVHD) is the leading cause of morbidity and mortality after allogeneic hematopoietic cell transplantation (HCT). Approximately 35% to 50% of HCT recipients develop aGVHD; however, there are no validated diagnostic and predictive blood biomarkers for aGVHD in clinica...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Xiao, Bin, Wang, Yu, Li, Wei, Baker, Megan, Guo, Jian, Corbet, Kelly, Tsalik, Ephraim L., Li, Qi-Jing, Palmer, Scott M., Woods, Christopher W., Li, Zhiguo, Chao, Nelson J., He, You-Wen
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Hematology 2013
Pynciau:
Transplantation
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3821726/
https://ncbi.nlm.nih.gov/pubmed/24041574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-06-510586
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg